Directori de persones
Jose Manuel Valdivielso Revilla

Jose Manuel Valdivielso Revilla

Grau: Doctor/a

973 702 952
valdivielso(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-5673-2009

Publicacions

  • Fernandez, LM; Sanchez-Alvarez, JE; de la Tassa, CM; Fernandez, JJB; Maria, V; Fernandez, E; Valdivielso, JM; Betriu, A

    Risk factors associated with valvular calcification in patients with chronic kidney disease. Analysis of NEFRONA study

    Nefrologia 41 337-346. .

    [doi:10.1016/j.nefro.2020.08.012]

  • Kosanovic M; Llorente A; Glamoclija S; Valdivielso JM; Bozic M

    Extracellular Vesicles and Renal Fibrosis: An Odyssey toward a New Therapeutic Approach.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. .

    [doi:10.3390/ijms22083887]

  • Del Vecchio, L; Ekart, R; Ferro, CJ; Malyszko, J; Mark, PB; Ortiz, A; Sarafidis, P; Valdivielso, JM; Mallamaci, F; ERA-EDTA European Renal and Cardiovascular Medicine Working (EURECA-m) Group

    Intravenous iron therapy and the cardiovascular system: risks and benefits.

    CLINICAL KIDNEY JOURNAL 14 1067-1076. .

    [doi:10.1093/ckj/sfaa212]

  • Gorriz JL; Arroyo D; D'Marco L; Torra R; Tomás P; Puchades MJ; Panizo N; Pantoja J; Montomoli M; Llisterri JL; Pallares-Carratalá V; Valdivielso JM

    Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease.

    BMC NEPHROLOGY 22 110-110. .

    [doi:10.1186/s12882-021-02313-1]

  • Sánchez M; Sánchez E; Bermúdez-López M; Torres G; Farràs-Sallés C; Pamplona R; Castro-Boqué E; Valdivielso JM; Purroy F; Martínez-Alonso M; Godoy P; Mauricio D; Fernández E; Hernández M; Rius F; Lecube A

    Clinical Usefulness of Anthropometric Indices to Predict the Presence of Prediabetes. Data from the ILERVAS Cohort.

    Nutrients 13 1-15. .

    [doi:10.3390/nu13031002]

  • Sapiña-Beltrán E; Gracia-Lavedan E; Torres G; Gaeta AM; Paredes J; Mayoral A; Fernández E; Bermúdez-López M; Valdivielso JM; Farràs-Salles C; Pamplona R; Lecube A; de Batlle J; Barbé F; Dalmases M

    Prevalence of Obstructive Sleep Apnoea and Its Association With Atherosclerotic Plaques in a Cohort of Subjects With Mild-Moderate Cardiovascular Risk.

    ARCHIVOS DE BRONCONEUMOLOGIA 58 490-497. .

    [doi:10.1016/j.arbres.2021.01.026]

  • Mark PB; Vecchio LD; Valdivielso JM; Malyszko J

    Same rhythm, different song-approaches to atrial fibrillation management by cardiologists and nephrologists.

    CLINICAL KIDNEY JOURNAL 14 9-13. .

    [doi:10.1093/ckj/sfaa146]

  • Bermúdez-López, Marcelino; Martínez-Alonso, Montse; Castro-Boqué, Eva; Betriu, Àngels; Cambray, Serafí; Farràs, Cristina; Barbé, Ferran; Pamplona, Reinald; Lecube, Albert; Mauricio, Dídac; Purroy, Francisco; Valdivielso, José Manuel; Fernández, Elvira

    Localización y carga de ateromatosis subclínica en población con un riesgo cardiovascular bajo-moderado: estudio ILERVAS

    REVISTA ESPANOLA DE CARDIOLOGIA 74 1043-1054. .

    [doi:10.1016/j.recesp.2020.09.024]

  • Cambray S; Bermudez-Lopez M; Bozic M; Valdivielso JM; NEFRONA investigators

    Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease.

    CLINICAL KIDNEY JOURNAL 13 1017-1024. .

    [doi:10.1093/ckj/sfaa014]

  • Bermudez-Lopez, M; Forne, C; Cambray, S; Bozic, M; Valdivielso, JM

    OUTCOMES AND HEALTHCARE RESOURCES UTILIZATION DIFFERENCES IN PATIENTS WITH AND WITHOUT SECONDARY HYPERPARATHYROIDISM FROM THE NEFRONA COHORT

    VALUE IN HEALTH 23 753-753. .

  • Marchant, V; Tejera-Munoz, A; Marquez-Exposito, L; Rayego-Mateos, S; Rodrigues-Diez, RR; Tejedor, L; Santos-Sanchez, L; Egido, J; Ortiz, A; Valdivielso, JM; Fraser, DJ; Lopez-Cabrera, M; Selgas, R; Ruiz-Ortega, M

    IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.

    Biomolecules 10 1-36. .

    [doi:10.3390/biom10101361]

  • Sumida K; Nadkarni GN; Grams ME; Sang Y; Ballew SH; Coresh J; Matsushita K; Surapaneni A; Brunskill N; Chadban SJ; Chang AR; Cirillo M; Daratha KB; Gansevoort RT; Garg AX; Iacoviello L; Kayama T; Konta T; Kovesdy CP; Lash J; Lee BJ; Major RW; Metzger M; Miura K; Naimark DMJ; Nelson RG; Sawhney S; Stempniewicz N; Tang M; Townsend RR; Traynor JP; Valdivielso JM; Wetzels J; Polkinghorne KR; Heerspink HJL

    Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis : An Individual Participant-Based Meta-analysis.

    ANNALS OF INTERNAL MEDICINE 173 426-435. .

    [doi:10.7326/M20-0529]

Projectes

  • Calprotectin as a new companion biomarker and associated drug target for premature vascular aging in chronic kidney disease and type 2 diabetes
  • Papel de la señalizacion renal por IGF en los eventos tempranos de la enfermedad renal crónica
  • Crosstalk between vascular vitamin D signaling and bone homeostasis in CKD. Implications in mineral metabolism.
  • Estancias de personal docente y/o investigador senior en centros extranjeros 2022
  • El primer Estudio de asociación de genoma completo (GWAS) con enfermedad coronaria poblacional a 10 años en más de 100.000 participantes para personalizar la prevención cardiovascular en España
  • Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
  • SPAIN CKD CAUSE (SPACKDC)
  • Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
  • INVESTIGO 2022: Grup de recerca translacional vascular i renal
  • Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
  • Acciones de Dinamización "Europa Investigación 2020"
  • Contratos Sara Borrell